# Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma

> **NCT02063022** · PHASE3 · COMPLETED · sponsor: **Italian Sarcoma Group** · enrollment: 278 (actual)

## Conditions studied

- Ewing's Sarcoma

## Interventions

- **DRUG:** Standard treatment (as per protocol ISG SSG III)
- **DRUG:** Intensified chemotherapy

## Key facts

- **NCT ID:** NCT02063022
- **Lead sponsor:** Italian Sarcoma Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-22
- **Primary completion:** 2022-04-14
- **Final completion:** 2022-04-14
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2022-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02063022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02063022, "Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02063022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*